Millennium Dental
This article was originally published in The Gray Sheet
Executive Summary
PerioLase periodontal laser developed with Lares Research clears FDA June 10. The Los Angeles company predicts that introduction of the product will increase treatment of periodontal disease, which has traditionally been more invasive. Intended for all soft tissue procedures, the PerioLase employs TruePulse technology, featuring "precise, small flexible quartz fibers and an easy-access handpiece with MultiVariable Pulse operation, specially created to optimize patient comfort and safety," Millennium explains
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.